Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia.

Lee TY, Ezelle HJ, Venkataraman T, Lapidus RG, Scheibner KA, Hassel BA.

J Interferon Cytokine Res. 2013 Jan;33(1):34-42. doi: 10.1089/jir.2012.0062. Epub 2012 Oct 31.

2.

MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein.

Hershkovitz-Rokah O, Modai S, Pasmanik-Chor M, Toren A, Shomron N, Raanani P, Shpilberg O, Granot G.

Cancer Lett. 2015 Jan 28;356(2 Pt B):597-605. doi: 10.1016/j.canlet.2014.10.006. Epub 2014 Oct 8.

PMID:
25305453
3.
4.

BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.

Xu C, Fu H, Gao L, Wang L, Wang W, Li J, Li Y, Dou L, Gao X, Luo X, Jing Y, Chim CS, Zheng X, Yu L.

Oncogene. 2014 Jan 2;33(1):44-54. doi: 10.1038/onc.2012.557. Epub 2012 Dec 3.

PMID:
23208504
5.

Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.

Hershkovitz-Rokah O, Modai S, Pasmanik-Chor M, Toren A, Shomron N, Raanani P, Shpilberg O, Granot G.

Cancer Lett. 2015 May 1;360(2):245-56. doi: 10.1016/j.canlet.2015.02.031. Epub 2015 Feb 16.

PMID:
25697481
6.

2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells.

Maran A, Waller CF, Paranjape JM, Li G, Xiao W, Zhang K, Kalaycio ME, Maitra RK, Lichtin AE, Brugger W, Torrence PF, Silverman RH.

Blood. 1998 Dec 1;92(11):4336-43.

7.

miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR/ABL1 protein.

Li Y, Wang H, Tao K, Xiao Q, Huang Z, Zhong L, Cao W, Wen J, Feng W.

Exp Cell Res. 2013 May 1;319(8):1094-101. doi: 10.1016/j.yexcr.2013.02.002. Epub 2013 Feb 18.

PMID:
23428668
8.

Human RNase L tunes gene expression by selectively destabilizing the microRNA-regulated transcriptome.

Rath S, Donovan J, Whitney G, Chitrakar A, Wang W, Korennykh A.

Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15916-21. doi: 10.1073/pnas.1513034112. Epub 2015 Dec 14.

9.

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells.

Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler MU, Ganser A, Eder M, Scherr M.

Blood. 2007 May 15;109(10):4399-405. Epub 2007 Feb 6.

10.

The proto-oncogene Pim-1 is a target of miR-33a.

Thomas M, Lange-Grünweller K, Weirauch U, Gutsch D, Aigner A, Grünweller A, Hartmann RK.

Oncogene. 2012 Feb 16;31(7):918-28. doi: 10.1038/onc.2011.278. Epub 2011 Jul 11.

PMID:
21743487
11.

MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia.

Xishan Z, Ziying L, Jing D, Gang L.

Sci Rep. 2015 Jul 31;5:12460. doi: 10.1038/srep12460.

12.

MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α.

Yang P, Ni F, Deng RQ, Qiang G, Zhao H, Yang MZ, Wang XY, Xu YZ, Chen L, Chen DL, Chen ZJ, Kan LX, Wang SY.

Mol Cancer. 2015 Nov 6;14:190. doi: 10.1186/s12943-015-0465-3.

13.

MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.

Kaymaz BT, Cetintaş VB, Aktan C, Kosova B.

Tumour Biol. 2014 Sep;35(9):8733-42. doi: 10.1007/s13277-014-2138-z. Epub 2014 May 30.

PMID:
24870597
14.

miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.

Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J, Zheng Y, Bi F.

Cancer Lett. 2011 Feb 28;301(2):151-60. doi: 10.1016/j.canlet.2010.11.009. Epub 2010 Dec 24.

PMID:
21186079
15.

MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3).

Yang CH, Yue J, Pfeffer SR, Fan M, Paulus E, Hosni-Ahmed A, Sims M, Qayyum S, Davidoff AM, Handorf CR, Pfeffer LM.

J Biol Chem. 2014 Sep 5;289(36):25079-87. doi: 10.1074/jbc.M114.593863. Epub 2014 Jul 24.

16.

MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2.

Wang XF, Shi ZM, Wang XR, Cao L, Wang YY, Zhang JX, Yin Y, Luo H, Kang CS, Liu N, Jiang T, You YP.

J Cancer Res Clin Oncol. 2012 Apr;138(4):573-84. doi: 10.1007/s00432-011-1114-x. Epub 2011 Dec 30.

PMID:
22207524
17.

Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328.

Paduano F, Dattilo V, Narciso D, Bilotta A, Gaudio E, Menniti M, Agosti V, Palmieri C, Perrotti N, Fusco A, Trapasso F, Iuliano R.

FEBS J. 2013 Jan;280(2):401-12. doi: 10.1111/j.1742-4658.2012.08624.x. Epub 2012 May 30.

18.

MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.

Wang Y, Tang Q, Li M, Jiang S, Wang X.

Biochem Biophys Res Commun. 2014 Feb 7;444(2):199-204. doi: 10.1016/j.bbrc.2014.01.028. Epub 2014 Jan 16.

PMID:
24440701
19.

miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.

Chen X, Hao B, Han G, Liu Y, Dai D, Li Y, Wu X, Zhou X, Yue Z, Wang L, Cao Y, Liu J.

J Cell Biochem. 2015 Feb;116(2):225-32. doi: 10.1002/jcb.24949.

PMID:
25160587
20.

MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.

Zhang X, Li D, Li M, Ye M, Ding L, Cai H, Fu D, Lv Z.

Int J Cancer. 2014 Jan 15;134(2):257-67. doi: 10.1002/ijc.28141. Epub 2013 Sep 18.

Supplemental Content

Support Center